Literature DB >> 2628742

Opposing influences of glucocorticoid and retinoic acid on transcriptional control in preosteoblasts.

K W Ng1, S S Manji, M F Young, D M Findlay.   

Abstract

UMR 201 is a nontransformed rat clonal cell line derived from neonatal calvaria with phenotypic characteristics of preosteoblasts. Retinoic acid strongly induces expression of alkaline phosphatase and its mRNA in these cells. Dexamethasone substantially reduced the retinoic acid-induced expression of alkaline phosphatase. This apparent interaction between dexamethasone and retinoic acid effects raised the possibility that interactions may extend to other osteoblast-related phenotypic characteristics in UMR 201 cells. Treatment with dexamethasone resulted in a decrease in the expression of mRNA for pro-alpha 1(I) collagen, but upon coincubation with 1 microM retinoic acid for 24 h, the decrease in mRNA for pro-alpha 1(I) collagen was abrogated. Dexamethasone (Dex) treatment caused a dose-dependent increase in osteonectin mRNA, half maximally effective between 1 nM and 10 nM Dex. One micromolar of retinoic acid alone led to a small increase in expression of osteonectin mRNA but prevented any further increase when Dex was added to retinoic acid-treated cells. To study transcriptional control, osteonectin genomic fragments were linked to the bacterial reporter gene, chloramphenicol acetyltransferase, and introduced by transfection into UMR 201 cells. Dexamethasone increased the transcriptional activity of an osteonectin-chloramphenicol acetyltransferase construct; 100 nM Dex resulted in a 3-fold increase over control cells which was attenuated when 1 microM retinoic acid was added to the incubation, while retinoic acid alone resulted in a 2-fold increase in transcriptional activity. Finally, it was noted that coincubation with retinoic acid and Dex stimulated the proliferation of UMR 201 cells when compared with either treatment alone. This study shows the potential importance of hormonal interactions in the expression of osteoblast function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2628742     DOI: 10.1210/mend-3-12-2079

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  12 in total

Review 1.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.

Authors:  John R Harrison; Henning W Woitge; Barbara E Kream
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433.

Authors:  Neha S Dole; Kristina Kapinas; Catherine B Kessler; Siu-Pok Yee; Douglas J Adams; Renata C Pereira; Anne M Delany
Journal:  J Bone Miner Res       Date:  2015-04       Impact factor: 6.741

3.  Osteopenia and decreased bone formation in osteonectin-deficient mice.

Authors:  A M Delany; M Amling; M Priemel; C Howe; R Baron; E Canalis
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor.

Authors:  H Herschel Conaway; Amir Pirhayati; Emma Persson; Ulrika Pettersson; Olle Svensson; Catharina Lindholm; Petra Henning; Jan Tuckermann; Ulf H Lerner
Journal:  J Biol Chem       Date:  2011-06-29       Impact factor: 5.157

5.  Retinoic acid regulates commitment of undifferentiated mesenchymal stem cells into osteoblasts and adipocytes.

Authors:  Kunihiro Hisada; Kenji Hata; Fumitaka Ichida; Takuma Matsubara; Hideo Orimo; Tamaki Nakano; Hirohumi Yatani; Riko Nishimura; Toshiyuki Yoneda
Journal:  J Bone Miner Metab       Date:  2012-09-27       Impact factor: 2.626

6.  A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene.

Authors:  P C Lucas; R M O'Brien; J A Mitchell; C M Davis; E Imai; B M Forman; H H Samuels; D K Granner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

7.  Regulation of the expression of alkaline phosphatase in a human breast-cancer cell line.

Authors:  T C Chang; J K Wang; M W Hung; C H Chiao; L C Tsai; G G Chang
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

8.  Osteonectin/SPARC polymorphisms in Caucasian men with idiopathic osteoporosis.

Authors:  A M Delany; D J McMahon; J S Powell; D A Greenberg; E S Kurland
Journal:  Osteoporos Int       Date:  2007-12-15       Impact factor: 4.507

9.  Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells.

Authors:  S Warabi; Y Tachibana; M Kumegawa; Y Hakeda
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

10.  Thrombospondin-2 and SPARC/osteonectin are critical regulators of bone remodeling.

Authors:  Anne M Delany; Kurt David Hankenson
Journal:  J Cell Commun Signal       Date:  2009-10-28       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.